Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1755 ARTÍCULOS , VIENDO DEL 1021 AL 1035

Mild Behavioral Impairment: An Early Sign and Predictor of Alzheimer's Disease Dementia

Jiang F, Cheng C, Huang J, Chen Q, Le W.

Curr Alzheimer Res. 2022;19(6):407-419. doi: 10.2174/1567205019666220805114528.

The gut microbiome and Alzheimer's disease: Complex and bidirectional interactions

Tarawneh R, Penhos E.

Neurosci Biobehav Rev. 2022 Oct;141:104814. doi: 10.1016/j.neubiorev.2022.104814. Epub 2022 Aug 4.

Semantic processing and neurobiology in Alzheimer's disease and Mild Cognitive Impairment

Almeida VN, Radanovic M.

Neuropsychologia. 2022 Sep 9;174:108337. doi: 10.1016/j.neuropsychologia.2022.108337. Epub 2022 Aug 5.

Focal amyloid and asymmetric tau in an imaging-to-autopsy case of clinical primary progressive aphasia with Alzheimer disease neuropathology

Martersteck A, Ayala I, Ohm DT, Spencer C, Coventry C, Weintraub S, Bigio EH, Mesulam M-, Geula C, Rogalski E.

Acta Neuropathol Commun. 2022 Aug 9;10(1):111. doi: 10.1186/s40478-022-01412-w.

Leisure Activities and the Risk of Dementia: A Systematic Review and Meta-analysis

Su S, Shi L, Zheng Y, Sun Y, Huang X, Zhang A, Que J, Sun X, Shi J, Bao Y, Deng J, Lu L.

Neurology. 2022 Oct 10;99(15):e1651-e1663. doi: 10.1212/WNL.0000000000200929.

Effects of Selenium Supplementation in Patients with Mild Cognitive Impairment or Alzheimer's Disease: A Systematic Review and Meta-Analysis

Pereira ME, Souza JV, Galiciolli MEA, Sare F, Vieira GS, Kruk IL, Oliveira CS.

Nutrients. 2022 Aug 5;14(15):3205. doi: 10.3390/nu14153205.

Accelerated long-term forgetting in neurodegenerative disorders: A systematic review of the literature

Rodini M, De Simone MS, Caltagirone C, Carlesimo GA.

Neurosci Biobehav Rev. 2022 Oct;141:104815. doi: 10.1016/j.neubiorev.2022.104815. Epub 2022 Aug 10.

Can a serious game-based cognitive training attenuate cognitive decline related to Alzheimer's disease? Protocol for a randomized controlled trial

Brill E, Krebs C, Falkner M, Peter J, Henke K, Züst M, Minkova L, Brem AK, Klöppel S.

BMC Psychiatry. 2022 Aug 12;22(1):552. doi: 10.1186/s12888-022-04131-7.

Perspectives and challenges in patient stratification in Alzheimer's disease

Abdelnour C, Agosta F, Bozzali M, Fougère B, Iwata A, Nilforooshan R, Takada LT, Viñuela F, Traber M.

Alzheimers Res Ther. 2022 Aug 13;14(1):112. doi: 10.1186/s13195-022-01055-y.

The temporal lobe in typical and atypical Alzheimer disease

Migliaccio R, Cacciamani F.

Handb Clin Neurol. 2022;187:449-466. doi: 10.1016/B978-0-12-823493-8.00004-3.

Driving Ability Evaluation and Rehabilitation for People With Alzheimer's Disease and Related Dementias

Liu Z, Grant J, Simpson SP, Khattak A, Anderson JG, Gao Z, Zhao X.

Alzheimer Dis Assoc Disord. 2022 Oct-Dec 01;36(4):374-381. doi: 10.1097/WAD.0000000000000524. Epub 2022 Aug 19.

β-Amyloid promotes platelet activation and activated platelets act as bridge between risk factors and Alzheimer's disease

Li TR, Liu FQ.

Mech Ageing Dev. 2022 Oct;207:111725. doi: 10.1016/j.mad.2022.111725. Epub 2022 Aug 19.

Recent updates in the development of small molecules as potential clinical candidates for Alzheimer's disease: A review

Umar T, Meena R, Mustehasan, Kumar P, Khan AA.

Chem Biol Drug Des. 2022 Nov;100(5):674-681. doi: 10.1111/cbdd.14133. Epub 2022 Sep 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias